FHTX vs SONY
Foghorn Therapeutics Inc (FHTX) versus SONY (SONY) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
SONY (SONY) common stock.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
SONY does not have a complete income-statement cache yet.
FHTX currently screens at market cap $237.8M. SONY currently screens at market cap $0.
Not investment advice. Open the FHTX and SONY stock pages for the full models.
Not investment advice.